David Gutmann, MD, PhD

Clinical Expertise

Cancer predisposition syndromes

Research Interest

Our laboratory studies the molecular biology of nervous system tumors, including neurofibromatosis 1, neurofibromatosis 2 and tuberous sclerosis 2 tumor suppressor gene products. In addition, I direct the neurofibromatosis program at St. Louis Children's Hospital and am involved in several trials for these patients. Key words: Inherited cancer syndromes, neurofibromatosis, neuro-oncology.

Education

• 1980: MS, human genetics, University of Michigan, Ann Arbor
• 1984: PhD, microbiology and immunology, University of Michigan, Ann Arbor
• 1986: MD, University of Michigan

Training

• 1986 - 1990: Resident, neurology, University of Pennsylvania, Philadelphia
• 1990 - 1993: Postdoctoral fellow, human molecular genetics, Howard Hughes Medical Institute and University of Michigan, Ann Arbor

Board Certification

• 1992: American Board of Psychiatry and Neurology, Neurology

Journal Articles

Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.